Hall & Partners Opens Pharma Unit

Brand and communications research consultancy Hall & Partners has opened a new pharmaceutical division in Paris, headed by Clarissa Guengant Del Pup, who joins from Synovate Healthcare.

Part of the Omnicom Group's Diversified Agency Services (DAS), Hall & Partners has operations in London, New York, Los Angeles, Chicago, Seattle, Shanghai and Sydney, and will shortly add Berlin and Singapore.

Global CEO Vanella Jackson explained that the new division had resulted from requests from the firm's European pharma clients for 'fresh thinking, creativity and true expertise in branding'.

Guengant Del Pup joins with more than 13 years' experience in international market research, consulting and competitive intelligence within the global pharma industry. Most recently, she was Director/Country Manager at Synovate Healthcare France, prior to which she worked as Business Development Director/Group Head at Synovate Healthcare in London.

In her new role, with the title of European Partner, Guengant Del Pup is charged with adapting consumer research approaches to the healthcare industry.

Jackson commented: 'It is the right time to bring the thought leadership of Hall & Partners Health into the French market - and we are delighted to have Clarissa on board.'

Web site: www.hallandpartners.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Hall & Partners
• All news
• MrWeb info